197 related articles for article (PubMed ID: 2859185)
21. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the antihypertensive efficacy and safety of felodipine IV and nifedipine IV in patients with hypertensive crisis or emergency not responding to oral nifedipine.
Risler T; Bohm R; Wetzchewald D; Nast HP; Koch HH; Stein G; Erley CM
Eur J Clin Pharmacol; 1998 Jun; 54(4):295-8. PubMed ID: 9696952
[TBL] [Abstract][Full Text] [Related]
23. Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study.
Romito R; Pansini MI; Perticone F; Antonelli G; Pitzalis M; Rizzon P
J Clin Hypertens (Greenwich); 2003; 5(4):249-53. PubMed ID: 12939564
[TBL] [Abstract][Full Text] [Related]
24. Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension.
Hedner T; Elmfeldt D; Dahlöf C; Sjögren E
Drugs; 1987; 34 Suppl 3():125-31. PubMed ID: 3443058
[TBL] [Abstract][Full Text] [Related]
25. Felodipine compared to prazosin as additional therapy to a beta-blocking drug.
Chalmers J; Wing L; West M; Bune A; Johnston C; Jackson B; McGrath B; Mashford ML; Heath W; Westwood B
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S82-4. PubMed ID: 2455150
[TBL] [Abstract][Full Text] [Related]
26. Renal effects of felodipine in hypertensive patients with reduced renal function.
Herlitz H; Aurell M; Björck S; Granérus G
Drugs; 1985; 29 Suppl 2():192-7. PubMed ID: 3987548
[TBL] [Abstract][Full Text] [Related]
27. Felodipine in comparison with prazosin in hypertensive patients inadequately controlled on beta-blockade.
Westermann B; Houtzagers JJ; Meulesteen P
Drugs; 1985; 29 Suppl 2():159-60. PubMed ID: 2859186
[No Abstract] [Full Text] [Related]
28. Cross-over comparison of nifedipine Oros and felodipine extended release with blind 24 h ambulatory blood pressure assessments.
Taverner D; Marley J; Tonkin AL
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):909-13. PubMed ID: 10561813
[TBL] [Abstract][Full Text] [Related]
29. Effects of felodipine on rest and exercise heart rate and blood pressure in hypertensive patients.
Lorimer AR; McAlpine HM; Rae AP; Simpson IA; Barbour MP; Forret EA; Hill TW; Lawrie TD
Drugs; 1985; 29 Suppl 2():154-7. PubMed ID: 3886358
[No Abstract] [Full Text] [Related]
30. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
31. Calcium antagonists, a useful additional therapy in treatment resistant hypertension: comparison of felodipine ER and nifedipine Retard by 24-h ambulatory blood pressure monitoring.
Dees A; Kremer Hovinga T; Breed JG; Verstappen VM; Puister SM; Meems L
Neth J Med; 1997 Jan; 50(1):2-12. PubMed ID: 9038037
[TBL] [Abstract][Full Text] [Related]
32. Monotherapy with felodipine, a new calcium antagonist, in mild and moderate hypertension.
Hamilton DV; Barnes PC; Bowles RM; Rajaratnam DV; Comerford MB; Ginks WR; Ginks SE; Goves JR; Grabau WJ; Malcolm JP
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S111-3. PubMed ID: 2455107
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
34. Control of hypertension in elderly patients with felodipine and metoprolol: a double-blind, placebo-controlled clinical trial.
Freeling P; Davis RH; Goves JR; Burton RH; Orme-Smith EA
Br J Clin Pharmacol; 1987 Oct; 24(4):459-64. PubMed ID: 3318897
[TBL] [Abstract][Full Text] [Related]
35. Control of blood pressure in hypertensive patients with felodipine extended release or nifedipine retard.
Littler WA
Br J Clin Pharmacol; 1990 Dec; 30(6):871-8. PubMed ID: 2288833
[TBL] [Abstract][Full Text] [Related]
36. Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.
Maclean D; Mitchell ET; Coulson RR; Fitzsimons TJ; McDevitt DG
Br J Clin Pharmacol; 1988 Apr; 25(4):425-31. PubMed ID: 3289598
[TBL] [Abstract][Full Text] [Related]
37. Felodipine. A calcium-inhibiting vasodilator in refractory hypertension.
Andersson OK; Granérus G; Hedner T
Drugs; 1985; 29 Suppl 2():102-8. PubMed ID: 3886356
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.
Waller PC; Solomon SA; Ramsay LE
Br J Clin Pharmacol; 1987 Nov; 24(5):591-7. PubMed ID: 2893636
[TBL] [Abstract][Full Text] [Related]
39. A parallel group randomised comparative study of felodipine and nifedipine in hypertension.
Sharma SM; Sethi KK; Kaul UA; Arora R; Khalilullah M
Indian Heart J; 1991; 43(3):171-3. PubMed ID: 1800302
[TBL] [Abstract][Full Text] [Related]
40. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
